 Englewood Cliffs NJ, Aug. 11, 2021 GLOBE NEWSWIRE -- Silo Pharma, Inc. OTCQB:SILO, a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, today announced that Silos joint venture partner, ZYLO Therapeutics, completed its first inspection with the SC Board of Pharmacy and will move forward with the Department of Health and Environmental Control. 